Home/Filings/4/0000899243-20-021756
4//SEC Filing

Fink Eric 4

Accession 0000899243-20-021756

CIK 0001629137other

Filed

Aug 6, 8:00 PM ET

Accepted

Aug 7, 4:09 PM ET

Size

7.3 KB

Accession

0000899243-20-021756

Insider Transaction Report

Form 4
Period: 2020-08-05
Fink Eric
Chief Human Resources Officer
Transactions
  • Sale

    Common Stock

    2020-08-05$70.10/sh950$66,5960 total
  • Sale

    Common Stock

    2020-08-05$69.32/sh1,504$104,255950 total
Footnotes (3)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2020.
  • [F2]Represents the weighted average sale price of the shares sold ranging from $68.855 to $69.75 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]Represents the weighted average sale price of the shares sold ranging from $69.98 to $70.30 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Global Blood Therapeutics, Inc.

CIK 0001629137

Entity typeother

Related Parties

1
  • filerCIK 0001784038

Filing Metadata

Form type
4
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 4:09 PM ET
Size
7.3 KB